2 FTSE 100 growth giants that could help you retire early

These FTSE 100 (INDEXFTSE:UKX) growth stocks could be big winners, says G A Chester.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

When you look at the history of the FTSE 100 over the long term, you’ll find lots of companies clustered around the average performance mark — but only a few really big winners and, of course, some big underperformers.

Today, I’m looking at two stocks that I believe have the credentials to deliver outsize returns for investors today. Indeed, I believe the growth prospects of these two firms are so strong that they could even help you retire early.

World leader

Last year was transformative for drugmaker Shire (LSE: SHP). Its $32bn merger with US firm Baxalta created the world leader in rare diseases. Being the global number one in a large and expanding market gives Shire the potential to deliver superior returns for investors in the decades to come.

In its annual results, released in February, the company reported that the Baxalta integration is progressing ahead of schedule, with operating expense synergy initiatives bearing fruit earlier than expected and legacy Baxalta products transitioning quickly onto Shire’s commercial platform. I’m expected further positive news on the progress of the integration when the company announces its Q1 results next Tuesday.

In addition to the existing portfolio of drugs, Shire’s pipeline is now stronger and deeper than it’s ever been, making chief executive Flemming Ornskov “extremely optimistic” about the company’s long-term growth prospects. I believe the valuation at the current share price of 4,625p represents a great opportunity for investors to buy into these prospects.

Company guidance on diluted earnings per share (EPS) for 2017 is $4.87 to $5.07, compared with a pro forma $4.37 last year, giving growth of 11.4% to 16%. At current exchange rates, the EPS guidance equates to 380p to 396p, giving an undemanding price-to-earnings (P/E) ratio at the 388p mid-point of 11.9.

Pioneering powerhouse

Worldpay (LSE: WPG) is another stock I believe could deliver outsized returns. This card, online and contactless payments processor serves 400,000 merchants in 126 currencies across 146 countries, offering over 300 payment methods. It’s the number one processor in the UK (42% of all transactions), as well as one of the leading global operators.

The move from cash to electronic transactions is a great structural growth driver for Worldpay, but this pioneering company is also aiming to lead the way in expanding global reach, data analytics and optimisation, and the emerging field of integrated payments.

All of this adds up to a business that could deliver tremendous growth and returns for shareholders long into the future. In the shorter term, analysts have been regularly upgrading their earnings forecasts for 2017 and 2018. As things presently stand, with the shares at 302p, the P/E is 22.2, falling to 19.2.

I wouldn’t be surprised to see further earnings upgrades, bringing the P/Es down but the investment case doesn’t rest on that. I believe the shares are very buyable at their current level, based on what I see as the company’s terrific long-term growth prospects.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended Worldpay. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mixed-race female couple enjoying themselves on a walk
Investing Articles

£7,000 in savings? Here’s what I’d do to turn that into a £1,160 monthly passive income

With some careful consideration, it's possible to make an excellent passive income for life with UK shares. This is how…

Read more »

Investing Articles

If I’d invested £1k in Amazon stock when it went public, here’s what I’d have today

Amazon stock has been one of the biggest winners over the last couple of decades. Muhammad Cheema takes a look…

Read more »

Investing Articles

If I’d put £5,000 in Nvidia stock 5 years ago, here’s what I’d have now

Nvidia stock has been a great success story in the past few years. This Fool breaks down how much he'd…

Read more »

Young black woman walking in Central London for shopping
Investing Articles

Could investing in a Shein IPO make my ISA shine?

With chatter that London might yet see a Shein IPO, our writer shares his view on some possible pros and…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

The FTSE 100 reached record highs in April! Here’s what investors should consider buying in May

The FTSE 100 continues to impress in 2024 as last month it reached new highs. Here are two stocks investors…

Read more »

Investing Articles

Despite hitting a 52-week high, Coca-Cola HBC stock still looks great value

Our writer reckons one flying UK share that has been participating in the recent FTSE 100 bull run remains a…

Read more »

Investing Articles

Is this the best stock to invest in right now?

Roland Head explains why he likes this FTSE 250 business so much and wonders if it could be the best…

Read more »

Cheerful young businesspeople with laptop working in office
Investing Articles

With impressive 7% dividend yields, I’d seriously consider these 2 popular British shares to buy in May

Picking the right dividend shares to buy can result in spectacular returns. This Fool is weighing the prospects of these…

Read more »